[L-DOPA-and dopa-decarboxylase inhibitor combination for the treatment of Parkinsonism].
作者信息
Fujimori N, Kito S, Yamamoto M, Itoga E, Kosaka K
出版信息
Nihon Rinsho. 1974 Mar;32(3):579-86.
PMID:4859014
Abstract
摘要
相似文献
1
[L-DOPA-and dopa-decarboxylase inhibitor combination for the treatment of Parkinsonism].左旋多巴与多巴脱羧酶抑制剂联合治疗帕金森病
Nihon Rinsho. 1974 Mar;32(3):579-86.
2
[Decarboxylase inhibitor given in combination with l-dopa. A new therapeutic principal in parkinsonism].
Tidsskr Nor Laegeforen. 1973 Oct 10;93(28):2113-5.
3
4
5
[Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor].
Munch Med Wochenschr. 1973 Apr 20;115(16):711-3.
6
[Treatment of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor].左旋多巴与脱羧酶抑制剂治疗帕金森综合征
Arch Invest Med (Mex). 1974;5(2):105-16.
7
Letter: Treatment of Huntington's chorea.信件：亨廷顿舞蹈症的治疗
N Engl J Med. 1973 Nov 29;289(22):1201. doi: 10.1056/NEJM197311292892219.
8
L-Dopa, B 6 , and alpha-methyldopa hydrazine.左旋多巴、维生素B6和α-甲基多巴肼。
Confin Neurol. 1973;35(3):186-92.
9
[Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
Rev Med Chil. 1973 Jun;101(6):452-5.
Zotero 插件